Condition
MERS
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (2)
Trial Status
Unknown3
Clinical Trials (3)
Showing 3 of 3 trials
NCT04130594Phase 1Unknown
Study of Safety and Immunogenicity of BVRS-GamVac
NCT04128059Phase 1Unknown
Study of Safety and Immunogenicity of BVRS-GamVac-Combi
NCT04672577Unknown
Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria
Showing all 3 trials